Results for tag: "Cotellic"

Cotellic is a prescription medication used to treat advanced melanoma, a type of skin cancer. It is a combination of two drugs, cobimetinib and vemurafenib, which work together to inhibit the growth of cancer cells. Cotellic is used in combination with the chemotherapy drug Zelboraf, and is approved for use in adults with BRAF V600 mutation-positive melanoma. Cotellic works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. Cotellic is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It is currently the only approved combination therapy for advanced melanoma. The Cotellic market is made up of pharmaceutical companies that produce and market the drug. These companies include Genentech, a subsidiary of Roche, and Exelixis, which developed the drug in collaboration with Roche. Other companies in the market include Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more